Clinical trials
Phase 3 Kidney Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 2 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 1 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Active, not recruiting | 5 |
| Recruiting | 4 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 3 |
| Bayer | 2 |
| Eli Lilly and Company | 2 |
| Tanabe Pharma Corporation | 2 |
| Alessandro Doria | 1 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Cerium Pharmaceuticals, Inc. | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Human Genome Sciences Inc., a GSK Company | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Kidney Diseases | 18 |
| Renal Insufficiency, Chronic | 9 |
| Glomerulonephritis | 4 |
| Urologic Diseases | 4 |
| Diabetes Mellitus, Type 2 | 3 |
| Diabetic Nephropathies | 3 |
| Glomerulonephritis, IGA | 3 |
| Nephritis | 3 |
| Autoimmune Diseases | 2 |
| Coronary Artery Disease | 2 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.